The Impact of Personality Pathology on Treatment Outcome in Late-life Panic Disorder.
Journal
Journal of psychiatric practice
ISSN: 1538-1145
Titre abrégé: J Psychiatr Pract
Pays: United States
ID NLM: 100901141
Informations de publication
Date de publication:
05 2020
05 2020
Historique:
entrez:
19
5
2020
pubmed:
19
5
2020
medline:
27
8
2021
Statut:
ppublish
Résumé
Comorbid personality disorders are assumed to negatively interfere with the treatment outcome of affective disorders. Data on late-life panic disorder remain unknown. We examined the association of personality pathology and treatment outcome related to age and treatment modality. An observational study on the effectiveness of cognitive-behavioral therapy (CBT) for panic disorder with agoraphobia among patients 18 to 74 years of age and randomized controlled comparison of paroxetine and CBT in older patients (60 y of age or older) were performed. The diagnosis of panic disorder was confirmed by the Anxiety Disorder Interview Schedule-Revised (ADIS-IV) and personality features were assessed with the Personality Diagnostic Questionnaire. The impact of personality features on either agoraphobic cognitions (Agoraphobic Cognitions Questionnaire) or avoidance behavior (Mobility Inventory Avoidance Scale) was examined by multiple linear regression analyses adjusted for sex, level of education, duration of illness, comorbid psychopathology, and baseline severity. The interaction between personality and age was examined among those treated with CBT (n=90); the interaction between personality and treatment modality was examined among the older subgroup (n=34). Cluster B personality pathology (evaluated on the basis of either Diagnostic and Statistical Manual of Mental Disorders, Third Edition, Revised (DSM-III-R) or Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition, Text Revision (DSM-IV-TR) criteria depending on the date of assessment) was negatively associated with outcomes of CBT in both younger and older adults with panic disorder and agoraphobia. Older adults with a higher number of features of any personality pathology or cluster A pathology had worse treatment outcomes when treated with paroxetine compared with CBT. Cluster B pathology had a detrimental effect on CBT treatment outcome for panic disorder in both age groups. In late-life panic disorder with comorbid personality pathology, CBT may be preferred over treatment with paroxetine.
Sections du résumé
BACKGROUND
Comorbid personality disorders are assumed to negatively interfere with the treatment outcome of affective disorders. Data on late-life panic disorder remain unknown. We examined the association of personality pathology and treatment outcome related to age and treatment modality.
METHODS
An observational study on the effectiveness of cognitive-behavioral therapy (CBT) for panic disorder with agoraphobia among patients 18 to 74 years of age and randomized controlled comparison of paroxetine and CBT in older patients (60 y of age or older) were performed. The diagnosis of panic disorder was confirmed by the Anxiety Disorder Interview Schedule-Revised (ADIS-IV) and personality features were assessed with the Personality Diagnostic Questionnaire. The impact of personality features on either agoraphobic cognitions (Agoraphobic Cognitions Questionnaire) or avoidance behavior (Mobility Inventory Avoidance Scale) was examined by multiple linear regression analyses adjusted for sex, level of education, duration of illness, comorbid psychopathology, and baseline severity. The interaction between personality and age was examined among those treated with CBT (n=90); the interaction between personality and treatment modality was examined among the older subgroup (n=34).
RESULTS
Cluster B personality pathology (evaluated on the basis of either Diagnostic and Statistical Manual of Mental Disorders, Third Edition, Revised (DSM-III-R) or Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition, Text Revision (DSM-IV-TR) criteria depending on the date of assessment) was negatively associated with outcomes of CBT in both younger and older adults with panic disorder and agoraphobia. Older adults with a higher number of features of any personality pathology or cluster A pathology had worse treatment outcomes when treated with paroxetine compared with CBT.
CONCLUSIONS
Cluster B pathology had a detrimental effect on CBT treatment outcome for panic disorder in both age groups. In late-life panic disorder with comorbid personality pathology, CBT may be preferred over treatment with paroxetine.
Identifiants
pubmed: 32421288
doi: 10.1097/PRA.0000000000000472
pii: 00131746-202005000-00002
doi:
Substances chimiques
Paroxetine
41VRH5220H
Types de publication
Journal Article
Observational Study
Randomized Controlled Trial
Langues
eng
Sous-ensembles de citation
IM
Pagination
164-174Références
Kessler RC, Berglund P, Demler O, et al. Lifetime prevalence and age-of-onset distributions of DSM-IV disorders in the National Comorbidity Survey Replication. Arch Gen Psychiatry. 2005;62:593–602.
Grant BF. Sociodemographic and psychopathologic predictors of first incidence of DSM-IV substance use, mood, and anxiety disorders: results from the Wave 2 National Epidemiologic Survey on Alcohol and Related Conditions. Mol Psychiatry. 2009;14:1051–1066.
Markowitz JS, Weissman MM, Ouellette R, et al. Quality of life in panic disorder. Arch Gen Psychiatry. 1989;46:984–992.
Schuurmans J, Van Balkom A. Late-life anxiety disorders: a review. Curr Psychiatry Rep. 2011;13:267–273.
Gould RL, Coulson MC, Howard RJ. Efficacy of cognitive behavioral therapy for anxiety disorders in older people: a meta-analysis and meta-regression of randomized controlled trials. J Am Geriatr Soc. 2012;60:218–229.
Hendriks GJ, Kampman M, Keijsers GP, et al. Cognitive-behavioral therapy for panic disorder with agoraphobia in older people: a comparison with younger patients. Depress Anxiety. 2014;31:669–677.
Marshall JR. Comorbidity and its effect on panic disorder. Bull Menninger Clin. 1996;60(suppl A):A39–A53.
Padesky CA. Schema-focused CT: comments and questions. International Cognitive Therapy Newsletter; 1988;4:5–7.
Slaap BR, den Boer JA. The prediction of nonresponse to pharmacotherapy in panic disorder: a review. Depress Anxiety. 2001;14:112–122.
Reich J. The effect of Axis II disorders on the outcome of treatment of anxiety and unipolar depressive disorders: a review. J Pers Disord. 2003;17:387–405.
Dreessen L, Arntz A, Luttels C, et al. Personality disorders do not influence the results of cognitive-behaviour therapies for anxiety disorders. Compr Psychiatry. 1994;35:265–274.
Reich J, Schatzberg A, Delucchi K. Empirical evidence of the effect of personality pathology on the outcome of panic disorder. J Psychiatr Res. 2018;107:42–47.
Hendriks GJ, Keijsers GP, Kampman M, et al. Predictors of outcome of pharmacological and psychological treatment of late-life panic disorder with agoraphobia. Int J Geriatr Psychiatry. 2012;27:146–150.
Kampman M, Keijsers GPJ, Hoogduin CAL, et al. Outcome prediction of cognitive behavior therapy for panic disorder: initial symptom severity is predictive for treatment outcome; comorbid anxiety or depressive disorder, cluster C personality disorders and initial motivation are not. Behav Cogn Psychother. 2008;36:99–112.
Hendriks GJ, Keijsers GP, Kampman M, et al. A randomized controlled study of paroxetine and cognitive-behavioural therapy for late-life panic disorder. Acta Psychiatr Scand. 2010;122:11–19.
Craske MG, Barlow DH Barlow DH. Panic disorders and agoraphobia. Clinical Handbook of Psychological Disorders. New York, NY: Guilford; 1993:1–47.
Craske MG, Meadows E, Barlow DH. Therapist Guide for the Mastery of Your Anxiety and Panic II and Agoraphobia Supplement. Albany, NY: Graywind Publications; 1994.
Ouwersloot door G, Brink Wvd, Diekstra en RFW. Diagnostiek van persoonlijkheidsstoornissen. Een evaluatie van Nederlandstalig instrumentarium [Diagnosis of personality disorders. An evaluation of Dutch instrucments]. Tijdschr Psychiatr. 1994;36:558–570.
Dingemans PMAJ, Sno HN. Meetinstrumenten bij persoonlijkheids-stoornissen [Measuring instruments for personality disorders]. Tijdschr Psychiatr. 2004;46:705–709.
Wilberg T, Dammen T, Friis S. Comparing Personality Diagnostic Questionnaire-4+ with longitudinal, expert, all data (LEAD) standard diagnoses in a sample with a high prevalence of axis I and axis II disorders. Compr Psychiatry. 2000;41:295–302.
Chambless DL, Caputo GC, Jasin SE, et al. The Mobility Inventory for Agoraphobia. Behav Res Ther. 1985;23:35–44.
De Beurs E. The Assessment and Treatment of Panic Disorder and Agoraphobia. Amsterdam, The Netherlands: Thesis Publishers; 1993.
Başoğlu M, Marks IM, Swinson RP, et al. Pre-treatment predictors of treatment outcome in panic disorder and agoraphobia treated with alprazolam and exposure. J Affect Disord. 1994;30:123–132.
de Beurs E, Lange A, van Dyck R, et al. Respiratory training prior to exposure in vivo in the treatment of panic disorder with agoraphobia: efficacy and predictors of outcome. Aust N Z J Psychiatry. 1995;29:104–113.
Chambless DL, Caputo GC, Bright P, et al. Assessment of fear of fear in agoraphobics: the Body Sensations Questionnaire and the Agoraphobic Cognitions Questionnaire. J Consult Clin Psychol. 1984;52:1090–1097.
Stevenson J, Meares R, Comerford A. Diminished impulsivity in older patients with borderline personality disorder. Am J Psychiatry. 2003;160:165–166.
Zanarini MC, Laudate CS, Frankenburg FR, et al. Predictors of self-mutilation in patients with borderline personality disorder: a 10-year follow-up study. J Psychiatr Res. 2011;45:823–828.
Mennin DS, Heimberg RG. The impact of comorbid mood and personality disorder in the cognitive-behavioral treatment of panic disorder. Clin Psychol Rev. 2000;20:339–357.
Porter E, Chambless DL. A systematic review of predictors and moderators of improvement in cognitive-behavioral therapy for panic disorder and agoraphobia. Clin Psychol Rev. 2015;42:179–192.
Balsis S, Gleason MEJ, Woods CM, et al. An item response theory analysis of DSM-IV personality disorder criteria across younger and older age groups. Psychol Aging. 2007;22:171–185.
Hendriks GJ, Oude Voshaar RC, Keijsers GP, et al. Cognitive-behavioural therapy for late-life anxiety disorders: a systematic review and meta-analysis. Acta Psychiatr Scand. 2008;117:403–411.
American Psychiatric Association (APA). Diagnostic and Statistical Manual of Mental Disorders, fifth edition. Arlington, VA: APA; 2013.
Widiger TA, Simonsen E. Alternative dimensional models of personality disorder: finding a common ground. J Pers Disord. 2005;19:110–130.
Clark LA. Assessment and diagnosis of personality disorder: perennial issues and an emerging reconceptualization. Annu Rev Psychol. 2007;58:227–257.
Newton-Howes G, Mulder R, Ellis PM, et al. Predictive utility of personality disorder in depression: comparison of outcomes and taxonomic approach. J Pers Disord. 2018;32:513–526.